The Impact of Interactive MRI-Based Radiologist Review on Radiotherapy Target Volume Delineation in Head and Neck Cancer

References

1. 1.↵
   1. Jackson A,
   2. Marks LB,
   3. Bentzen SM, et al

   . The lessons of QUANTEC: recommendations for reporting and gathering data on dose–volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys 2010;76:S155–60 doi:10.1016/j.ijrobp.2009.08.074 pmid:20171512

   CrossRefPubMed
2. 2.↵
   1. Chang AE,
   2. Matory YL,
   3. Dwyer AJ, et al

   . Magnetic resonance imaging versus computed tomography in the evaluation of soft tissue tumors of the extremities. Ann Surg 1987;205:340–48 doi:10.1097/00000658-198704000-00002 pmid:3032120

   CrossRefPubMed
3. 3.↵
   1. Bird D,
   2. Scarsbrook AF,
   3. Sykes J, et al

   . Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma. BMC Cancer 2015;15:844 doi:10.1186/s12885-015-1867-8 pmid:26530182

   CrossRefPubMed
4. 4.↵
   Head and Neck Cancer: RCR Consensus Statements. The Royal College of Radiologists; 2022. https://www.rcr.ac.uk/publication/head-and-neck-cancer-rcr-consensus-statements. Accessed November 1, 2022
5. 5.↵
   1. Van Herk M

   . Errors and margins in radiotherapy. Semin Radiat Oncol 2004;14:52–64 doi:10.1053/j.semradonc.2003.10.003 pmid:14752733

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Prestwich RJ,
   2. Sykes J,
   3. Carey B, et al

   . Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography? Clin Oncol (R Coll Radiol) 2012;24:577–89 doi:10.1016/j.clon.2012.04.002 pmid:22592142

   CrossRefPubMed
7. 7.↵
   1. Braunstein S,
   2. Glastonbury CM,
   3. Chen J, et al

   . Impact of neuroradiology-based peer review on head and neck radiotherapy target delineation. AJNR Am J Neuroradiol 2017;38:146–53 doi:10.3174/ajnr.A4963 pmid:27811130

   Abstract/FREE Full Text
8. 8.↵
   1. Chiu K,
   2. Hoskin P,
   3. Gupta A, et al

   . The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning. Br J Radiol 2022;95:20211219 doi:10.1259/bjr.20211219 pmid:34918547

   CrossRefPubMed
9. 9.↵
   1. Fong C,
   2. Sanghera P,
   3. Good J, et al

   . Implementing head and neck contouring peer review without pathway delay: the on-demand approach. Clin Oncol (R Coll Radiol) 2017;29:841–47 doi:10.1016/j.clon.2017.09.005 pmid:28988705

   CrossRefPubMed
10. 10.↵
    1. Ramasamy S,
    2. Murray LJ,
    3. Cardale K, et al

    . Quality assurance peer review of head and neck contours in a large cancer centre via a weekly meeting approach. Clin Oncol (R Coll Radiol) 2019;31:344–51 doi:10.1016/j.clon.2019.03.001 pmid:30890299

    CrossRefPubMed
11. 11.↵
    1. Mercieca S,
    2. Belderbos J,
    3. Gilson D, et al

    . Implementing the royal college of radiologists' radiotherapy target volume definition and peer review guidelines: more still to do? Clin Oncol (R Coll Radiology) 2019;31:706–10 doi:10.1016/j.clon.2019.07.021 pmid:31444023

    CrossRefPubMed
12. 12.↵
    1. Brock KK,
    2. Mutic S,
    3. McNutt TR, et al

    . Use of image registration and fusion algorithms and techniques in radiotherapy: report of the AAPM Radiation Therapy Committee Task Group No. 132. Med Phys 2017;44:e43-76 doi:10.1002/mp.12256 pmid:28376237

    CrossRefPubMed
13. 13.↵
    1. Grégoire V,
    2. Eisbruch A,
    3. Hamoir M, et al

    . Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006;79:15–20 doi:10.1016/j.radonc.2006.03.009 pmid:16616387

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Grégoire V,
    2. Levendag P,
    3. Ang KK, et al

    . CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003;69:227–36 doi:10.1016/j.radonc.2003.09.011 pmid:14644481

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Eelbode T,
    2. Bertels J,
    3. Berman M, et al

    . Optimization for medical image segmentation: theory and practice when evaluating with Dice score or Jaccard index. IEEE Trans Med Imaging 2020;39:3679–90 doi:10.1109/TMI.2020.3002417 pmid:32746113

    CrossRefPubMed
16. 16.↵
    1. Huttenlocher DP,
    2. Klanderman GA,
    3. Rucklidge WJ

    . Comparing images using the Hausdorff distance. IEEE Trans Pattern Anal Mach Intell 1993;15:850–63 doi:10.1109/34.232073

    CrossRef
17. 17.↵
    Royal College of Radiologists. Radiotherapy Target Volume Definition and Peer Review—RCR guidance. https://www.rcr.ac.uk/publication/radiotherapy-target-volume-definition-and-peer-review-second-edition-rcr-guidance. Accessed December 2021
18. 18.↵
    1. Lysack JT,
    2. Hoy M,
    3. Hudon ME, et al

    . Impact of neuroradiologist second opinion on staging and management of head and neck cancer. J Otolaryngol Head Neck Surg 2013;42:39 doi:10.1186/1916-0216-42-39 pmid:23739037

    CrossRefPubMed
19. 19.↵
    1. Gwynne S,
    2. Spezi E,
    3. Wills L, et al

    . Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case. Int J Radiat Oncol Biol Phys 2012;84:1037–42 doi:10.1016/j.ijrobp.2012.01.094 pmid:22878126

    CrossRefPubMed
20. 20.↵
    1. Tsang Y,
    2. Hoskin P,
    3. Spezi E, et al

    . Assessment of contour variability in target volumes and organs at risk in lung cancer radiotherapy. Tech Innov Patient Support Radiat Oncol 2019;10:8–12 doi:10.1016/j.tipsro.2019.05.001 pmid:32095541

    CrossRefPubMed
21. 21.↵
    1. Wong KH,
    2. Panek R,
    3. Bhide SA, et al

    . The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist’s perspective. Br J Radiol 2017;90:20160768 doi:10.1259/bjr.20160768 pmid:28256151

    CrossRefPubMed
22. 22.↵
    1. Giraud P,
    2. Elles S,
    3. Helfre S, et al

    . Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 2002;62:27–36 doi:10.1016/S0167-8140(01)00444-3 pmid:11830310

    CrossRefPubMed
23. 23.↵
    1. Grégoire V,
    2. Evans M,
    3. Le QT, et al

    . Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG ONCOLOGY, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol 2018;126:3–24 doi:10.1016/j.radonc.2017.10.016 pmid:29180076

    CrossRefPubMed